Table 2.

Core outcomes stratified by AUS score

	AUS: 0 (n=72)	AUS: 1 (n=230)	AUS: 2 (n=243)	AUS: 3 (n=186)
Duration of intravenous antibiotics (days) n; median (IQR)	69; 3 (1, 5)	209; 3 (2, 6)	216; 4 (3, 8)	169; 7 (3, 11)
Duration from episode to discharge (hours) n; median (IQR)	71; 72 (28, 228)	226; 96 (52, 192)	238; 120 (72, 240)	178; 192 (78, 336)
Outcomes
Positive blood culture (excl contaminants)	12 (17%)	36/229 (16%)	49 (20%)	57 (31%)
Significant infection requiring intravenous antibiotics	13 (18%)	29/229 (13%)	56 (23%)	57 (31%)
Representation within 7 days	5 (7%)	25 (11%)	12 (5%)	17 (9%)
Readmission within 7 days	5 (7%)	22 (10%)	11 (5%)	16 (9%)
ICU admission	0 (0%)	2/229 (1%)	4 (2%)	8 (4%)
Death from infection	0 (0%)	0/229 (0%)	0 (0%)	2 (1%)
Death from other cause	0 (0%)	0/229 (0%)	3 (1%)	2 (1%)

All data are count (%), unless otherwise specified.

AUS, Australian-UK-Swiss; ICU, intensive care unit.